About this trial
The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.
Eligibility criteria
Qualifiers
Have been diagnosed with lung cancer
Reside in a rural county as determined by a Rural Urban Continuum Code (RUC) of 4 or higher
Be at least 18 years of age or older
Be able to communicate effectively in English
Disqualifiers
Have significant psychiatric disturbance that requires a higher level of care
Have substance abuse/dependence that requires a higher level of care
Are participating in another lung cancer survivorship care intervention
Have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program
Trial design
Treatments tested in this trial
- Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program
- Enhanced Usual Care
Treatment groups
Sponsors and collaborators
Jerod L Stapleton, PhD
Lead sponsor
University of Kentucky
Sponsor institution
University of Louisville
Collaborator
G02 for Lung Cancer
Collaborator
National Cancer Institute (NCI)
Collaborator